[1] HOBERT M A, HOFMANN W, BARTSCH T, et al.Diagnosis and treatment of vascular dementia[J]. Z Gerontol Geriatr,2020,53(7):687-698. [2] BATTLE D E.Diagnostic and Statistical Manual of Mental Disorders (DSM)[J]. Codas,2013,25(2):191-192. [3] IADECOLA C, DUERING M, HACHINSKI V, et al.Vascular Cognitive Impairment and Dementia:JACC Scientific Expert Panel[J]. J Am Coll Cardiol,2019,73(25):3326-3344. [4] 余文骁,王延江.亚洲血管性认知损害的流行病学现状和发展趋势[J].中国医学前沿杂志(电子版),2020,12(10):1-8. [5] SMITH E E.Clinical presentations and epidemiology of vascular dementia[J]. Clin Sci (Lond),2017,131(11):1059-1068. [6] SINHA K, SUN C, KAMARI R, et al.Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia[J]. Drug Discov Today,2020,25(4):793-799. [7] ZHANG X, SU J, GAO C, et al.Progression in Vascular Cognitive Impairment: Pathogenesis,Neuroimaging Evaluation,and Treatment[J]. Cell Transplant,2019,28(1):18-25. [8] 石延榜,魏玉.基于数据挖掘的老年痴呆动物模型国内应用分析[J]. 中药药理与临床,2021,37(5):199-205. [9] 中国痴呆与认知障碍指南写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会.2018中国痴呆与认知障碍诊治指南(一):痴呆及其分类诊断标准[J].中华医学杂志,2018,98(13):965-970. [10] 苗明三,朱飞鹏.常用医药研究动物模型[M].常用医药研究动物模型,2007. [11] 苗明三,项丽玲,苗艳艳,等.短暂性脑缺血发作动物模型规范(草案)[J].中华中医药杂志,2019,34(4):1573-1577. [12] LONGA E Z, WEINSTEIN P R, CARLSON S, et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989,20(1):84-91. [13] BIEBER M, GRONEWOLD J, SCHARF A C, et al.Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion[J]. Stroke,2019,50(10):2875-2882. [14] 万海同. 中西医结合脑血管病临床与科研方法[M].中西医结合脑血管病临床与科研方法,2015. [15] 侯外方,张茂森,张琳,等.血管性认知障碍动物模型的研究进展[J].中国实验动物学报,2021,29(4):542-552. [16] YANG Y, ZHAO L, LI N, et al.Estrogen Exerts Neuroprotective Effects in Vascular Dementia Rats by Suppressing Autophagy and Activating the Wnt/β-Catenin Signaling Pathway[J]. Neurochem Res,2020,45(9):2100-2112. [17] 孟敏,李林.双侧颈总动脉结扎致血管性痴呆大鼠模型研究进展[J].中国康复理论与实践,2018,24(3):309-312. [18] ZONGFANG Z, WENJING L, ZHAOMIN C, et al. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction[J]. Pak J Pharm Sci,2020,33(5(Special)):2405-2411. [19] 李宁,白莉,苗明三.动物模型的表观-生化-病理-分子生物学指标的关联特点分析[J].中药药理与临床,2021,37(6):178-181. [20] YUAN Z, ZHOU H, ZHOU N, et al.Dynamic Evaluation Indices in Spatial Learning and Memory of Rat Vascular Dementia in the Morris Water Maze[J]. Sci Rep,2019,9(1):7224. [21] 余恒,周涛.调理气机法对血管性痴呆患者神经功能、颈总动脉血流动力学参数及血清氧化应激水平的影响[J]. 现代中西医结合杂志,2020,29(19): 2120-2124. [22] 李飞,王艳,姜天鑫,等.针灸治疗血管性痴呆及对血清VEGF和AChE的影响[J].中国针灸,2021,41(8):851-854. [23] 张晓红,杜双霞,闫欣,等.血清乙酰胆碱、一氧化氮水平与血管性痴呆患者认知功能的相关性研究[J].国际检验医学杂志,2017,38(15):2131-2133. [24] CONNELLY P J, ADAMS F, TAYAR Z I, et al.Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer’s disease[J]. BMC Neurol, 2019,19(1):88. [25] 赵秀茹,于靖,王滟.莫诺苷对血管性痴呆大鼠的治疗作用研究[J].中国临床解剖学杂志,2019,37(6):650-655. [26] HOLM H, NÄGGA K, NILSSON E D, et al. High circulating levels of midregional proenkephalin A predict vascular dementia: a population-based prospective study[J]. Sci Rep,2020,10(1):8027. [27] 王玮,靳贺超,耿秀超,等.血管性痴呆肾虚血瘀证病证结合大鼠模型的建立[J].中国中医基础医学杂志,2020,26(6):748-752. |